Neuroimmunology + Movement Disorders Flashcards

1
Q

Characteristics of transverse myelitis and causes

A
  • Monophasic inflammatory and demyelinating myelopathy affecting a portion of the spinal cord.
  • Subacute onset of weakness, sensory changes, bowel/bladder dysfunction

Causes:
Causes of transverse myelitis
- viral infections: varicella-zoster, herpes simplex, cytomegalovirus, Epstein-Barr, influenza, echovirus, human immunodeficiency virus
- bacterial infections: syphilis, Lyme disease
post-infectious (immune mediated)
- first symptom of multiple sclerosis (MS) or neuromyelitis optica (NMO)

Diagnostic criteria
- clinical features
- evidence of inflammation (leukocytosis in the CSF or contrast enhancement on MRI)
- CSF: elevated leukocytes, lack of oligoclonal bands, elevated IgG in CSF
The radiographical features are descriptive of transverse myelitis -inflammation across most of the spinal cord - Hyperintense T2 signal extending across the spinal cord, between the levels of T9 and T12.

Tx:

  • First line: high dose steroids
  • Plasma exchange in those who are unresponsive to corticosteroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Effect of severe vitamin B 12 deficiency

A

Causes subacute combined degeneration - dysfunction of corticospinal and dorsal columns

  • Spastic paresis with reduced vibration, proprioception and ataxia
  • Low vitamin b12, elevated methylmalonic acid, elevated homocysteine

Other causes of subacute combined degeneration

  • copper deficiency
  • malabsorption
  • Zinc toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Characteristics of optic neuritis

A
  • Subacute onset
  • PAIN ON EYE MOVEMENT
  • decreased visual acuity
  • decreased colour vision
  • Photopsia (sparkles of light)
  • Abnormal visual fields - central of cecocentral scotoma (central scotoma that joints up with the blind spot)
  • relative afferent pupillary defect
  • May or may not have disc swelling depending on the location of the inflammation
    Retrobulbar (no swelling) vs anterior neuropathy (swelling)
    Progresses to optic nerve disc pallor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of parkinsons disease

A

Aggregation of a-synuclein protein and formation of lewy body inclusions in the substantia nigra
Genes including autosomal dominant LRRK2 and autosomal recessive PARK2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical features of parkinsons

A
  1. Pre-symptomatic Stage
    - Anosmia
    - Constipation
    - REM sleep behavioural disorder
    - Mood changes, increased fatigue
  2. MOTOR Symptoms (symptomatic stage)
    TRAP
    - Tremor - usually unilateral at onset and remains asymmetric
    - Rigidity
    - Bradykinesia (most important diagnostic feature)
    - Postural instability
  3. Non motor syptoms: autonomic dysfuncion
    hyposmia
    constipation
    rapid eye movement sleep behaviour disorder - acting out of dreams secondary to loss of normal muscle paralysis during the dream phase of sleep
    Non motor may precede onset of motor symptoms by years
  4. Late Stage: cognitive and psychiatric manifestations
    depression is the most common feature (affects about 40%); dementia, psychosis and sleep disturbances may also occur
  • RBD is a marker of worse outcome for dementia
  • Reducing or withdrawing antidepressants alleviate RBD
  • Tx: Melatonin and clonazepam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the cognitive impairments in PD?

A

Cognitive impairments in PD are subcortical which implies they primarily involve slow processing speed, impaired short term memory and attention deficits with relative sparing of cortical functions such as language and declarative memory.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Levodopa
MOA
Indication
SE

A

L dopa/Carbidopa (Sinemet/Kinson)
L dopa/Benserazide (Madopar)

  • L dopa is the main precursor in doapmine synthesis
  • 1st line treatment for motor impairment
  • usually combined with a decarboxylase inhibitor (e.g. carbidopa or benserazide) to prevent peripheral metabolism of levodopa to dopamine
  • reduced effectiveness with time (usually by 2 years)

SE

  • Sedation, N+V
  • Dyskinesia (involuntary writhing movements)
  • Motor fluctuations ‘on-off’ effect
  • Punding: involves repetitive, often purposeless, stereotyped behaviours, such as sorting or diassembling that can be disruptive
  • Dopamine dysregulation syndrome is a form of addictive behaviour that occurs in up to 4% of patients and is characterised by compulsive overuse of dopaminergic medications, which are typically short acting (eg: levodopa and apomorphine), impairing physical, social and occupational functioning
dyskinesia
'on-off' effect
postural hypotension
cardiac arrhythmias
nausea & vomiting
psychosis
reddish discolouration of urine upon standing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are motor fluctuations and risk factors

A

Motor fluctuations present as periods of ‘on’ and ‘off’. During ‘on’ phase patients show a positive response to levodopa while during ‘off’ phase they show symptoms of Parkinson’s
- Wearing off classically associated with the later stages of PD

RF
Higher risk if:
- Longer disease duration 
- Higher levels of levodopa used 
- Younger onset PD 
- NOT the duration of L dopa therapy 

Tx
- Divide dose into increased frequency
- Addition of COMT inhibitor (eg: entacapone, tolcapone) or MAO inhibitor (selegiline, rasagline)
- New Medication: Safinamide - MOA B inhibitor + glutamate release inhibitor
Increased “on” time without troublesome dyskinesias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dyskinesia in PD and treatment

A
  • Dyskinesia (involuntary writhing movements)
  • More strongly associated to the AMOUNT of L dopa and disease duration

Tx

  • Minimise doses of dopaminergic medications
  • Amantadine: weak antagonist of the NMDA glutamate receptor, increase dopamine release, block dopamine reuptake
  • Break doses into higher frequency.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dopamine agonists in PD

A
  • Stimulate dopamine by binding directly to post synaptic dopamine receptors in the striatum

Non ergot dopamine agonists

  • Pramipexole, ropinirole (D2/3)
  • Transdermal rotigotine (D3)

Ergot derived dopamine agonists

  • Cabergoline, bromocriptine, pergolide (D1/2)
  • Complications of heart valve and retroperitoneal fibrosis

Not as effective as levodopa
Long acting, single dosing
Consider for night time for early morning off periods
Can be used as patch (rotigotine) when unable to give oral
Can be used for young patients

SE

  • Nauses, somnolence, oedema, dizziness, vomiting, hallucinations (more risk), hypotension
  • Worsens delirium
  • Impulse control disorders, punding (more specific to dopamine agonists)
  • Can still get motor fluctuations and dyskinesia but not as severe

Impulse control disorder:

  • Prior addictive personalities at greatest risk
  • Increase addictive behaviour based on prior personality
  • Hypersexuality, pathological gambling, excessive shopping/eating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MOA B inhibitors - rasgline, selagiline

A

MOA:
MAO-B inhibitor: inhibits the breakdown of dopamine secreted by the dopaminergic neurons

  • As effective as dopamine agonist if not slightly better
  • Used in mild/early symptoms or young patients
  • Can cause hepatic dysfunction
  • Most common SE - insomnia

Tyramine (found in cheese/wine) hypertensive crisis: tyramine release noradrenaline, ordinarily MAO-A would break down excess noradrenaline. Therefore excess in MOAI - adrenergic crisis
- Can still get motor fluctuations + dyskinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Best medication for PD

A

In terms of mobility and quality of life
L dopa > MAOI > DA
DA and MAOI had slightly better dyskinesia but no difference in motor fluctuations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hallucinations and Parkinsons

Medications in order of potency

A
  • Anticholinergic medications
  • Amantadine
  • Dopamine agonist
  • Monamine oxidase inhibitors
  • COMT
  • L dopa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Summary of PD medications

A
  • If young and mild: MAOI
  • Most patients: L dopa
  • If too parkinsonia: increase the dose
  • If motor fluctuations: break up the dose into increased frequency, COMT
  • If impairing dyskinesia: reduce dose and increase frequency if required
  • Never stop medications abruptly as this can lead to a parkinsonian crisis (neuroleptic malignant syndrome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What medications can be given for REM sleep?

A

Clonazepam

Melatonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What medications can be given for postural hypotension?

A

High salt diet
Domperidone
Fludrocortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What medications can be given for hallucinations?

A

For psychosis
- Reduce dopaminergic medication
- Clozapine
D1/2 and noradrenergic antagonist
Anticholinergic, antihistaminergic, antiserotonergic
- Quetiapine (5HT2 and D1/2 antagonist)
- Pimavanserin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Advanced therapy for parkinsons disease

A
  • Deep brain stimulation
  • Apomorphine infusion: dopamine agonist and it is administered as a continuous subcutaneous infusion or intermittent as needed. Apomorphine use decreases the off time and dyskinesia in PD patients
  • Intraduodenal levodopa: Continuous infusion through percutaneous gastrojejunostomy tube by an externally carried pump. - levodopa/carbidopa (duodopa) intestinal gel
  • Focused US sub-thalamotomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Where does DBS work the best for:
Motor fluctuations
Tremor
Gait freezing and postural instability

A
  • Motor fluctuations
    Subthalamic nucleus and globus pallidus
  • Tremor
    Subthalamic nucleus, thalamic

Gait freezing and postural instability
- Possibly helped by pedunculopontine nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Indications and complications for DBS

A

Choice of candidates for DBS

  • Response to dopaminergic therapy is most important while deciding DBS.
  • Presence of on–off fluctuations
  • Age < 70 years, although can be considered for higher age groups
  • Severe Dyskinesias impairing quality of life
  • Tremor that cannot be controlled with medication alone
  • Reasonable cognitive function

Complications of DBS

  • Neuropsychiatric, surgical complications, behavioural issues and mechanical malfunction related to the device can occur.
  • Higher risk of suicide may occur with STN targeted DBS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Prognosis for PD in terms of motor and non motor symptoms

A

Motor:

  1. Bradykinesia, Rigidity, Tremor
  2. Motor fluctuations, Dyskinesia
  3. Postural instability, freezing of gait, falls

Non Motor

  1. Constipation, RBD, Anosmia
  2. Orthostatic hypotension, dysphagia, early dementia
  3. Dementia, psychosis

Visual hallucination are often the first sign of advanced disease stage

22
Q

Features of dementia with lewy bodies

A

Recurrent visual hallucinations that are well formed and detailed

  • Insight
  • Animals, liliputian
  • Pareidolias: tendency to perceive a specific, often meaningful image in a random or ambiguous visual pattern
  • Spontaneous features of parkinsonism - poor responders to L dopa
  • Very sensitive to neuroleptics
  • Prominent early dementia
  • Less motor features
  • Early prominent visual hallucinations
  • Fluctuating consciousnesses (can be confused with delirium)
  • REM sleep disorder
  • Extreme neuroleptic sensitivity - patients with lewy body dementia have an increased risk of life-threatening akinetic crises (severe dopamine deficiency) under antipsychotic treatment.
  • Normally trial rivastigmine and give quetiapine
23
Q

Is it tau or synuclein involved in parkinson’s plus?

A
  • Lewy body dementia: a synuclein
  • Multi systems atrophy: synuclein
  • Progressive supranuclear palsy: tau
  • Corticobasalar degeneration: tau
24
Q

Characteristics of progressive supranuclear palsy (PSP)

A
  • Accumulation of tau
  • Vertical gaze palsy: Prominent supranuclear eye signs (vertical gaze) especially DOWNWARD gaze palsy
  • Early dementia
  • Axial rigidity and wide based gait - Axial rather than appendicular rigidity
  • Bulbar symptoms: dysphagia, recurrent aspiration pneumonia
  • Frontal Lobe abnormalities: apathy, disinhibition, impaired reasoning
  • Parkinsonian features – tend not be very levodopa responsive
  • Early falls, early swallow problems
  • Fall over steps (can’t look down, axial rigidity can’t bend neck)
  • Ptosis
  • Hummingbird sign on MRI/mickey mouse appearance (hollowed out mid brain – very concave, atrophy of midbrain structures with relatively intact pons region.
25
Characteristics of multisystem atrophy
- Accumulation of alpha synuclein - Triad of autonomic failure, parkinsonism, cerebellar signs - Primary autonomic failure: Postural hypotension, urinary retention, constipation, erectile dysfunction IX: Hot cross bun sign on MRI in pons (atrophy) - cross shaped hyperintensity on T2 weighted axial images of pons TX - Levodopa: often exacerbates orthostatic hypotension - Orthostatic hypotension - non pharm, fludrocortisone, midodrine - Urinary dysfunction: oxybutynin, solifenacin, mirabegron
26
Characteristics of corticalbasal degeneration
- Tau - Parkinsonism - rigidity, dystonia - Limb apraxia/ Alien limb phenomenon - Myoclonus - Cortical sensory signs - neglect, dysgraphaesthesia, astereognosis - Cognitive impairment - Speech apraxia or nonfluent aphasia Bilateral atrophy of basal ganglia Tx: - Botulin toxin for dystonia
27
Characteristics of restless legs
``` Diagnostic criteria URGE - urge to move legs usually with dysaethesias - rest induced - gets better with activity - evening or night worsening ``` Associations - Poor sleep hygiene - Coffee, stimulants - Iron deficiency - SSRis and dopamine antagonists can worsen RLS tx - L dopamine, dopamine agonists (pramipexole, rotigotine patch), gabapentin/pregablin, iron supplementation Restless legs syndrome (RLS) is a syndrome of spontaneous, continuous lower limb movements that may be associated with paraesthesia. It is extremely common, affecting between 2-10% of the general population. Males and females are equally affected and a family history may be present Clinical features uncontrollable urge to move legs (akathisia). Symptoms initially occur at night but as condition progresses may occur during the day. Symptoms are worse at rest paraesthesias e.g. 'crawling' or 'throbbing' sensations movements during sleep may be noted by the partner - periodic limb movements of sleeps (PLMS) ``` Causes and associations there is a positive family history in 50% of patients with idiopathic RLS iron deficiency anaemia uraemia diabetes mellitus pregnancy ``` The diagnosis is clinical although bloods such as ferritin to exclude iron deficiency anaemia may be appropriate Management simple measures: walking, stretching, massaging affected limbs treat any iron deficiency dopamine agonists are first-line treatment (e.g. Pramipexole, ropinirole) benzodiazepines gabapentin
28
Characteristics of fragile X associated tremor ataxia syndrome (FXTAS)
- Inherited movement disorder - X linked DOMINANT inheritance - Associated with FMR1 protein deficiency - CGG repeats - Cause intellectual disability, seizures, autism in early childhood Clinical Features - Intention tremor - Ataxia - Parkinsonism - Peripheral neuropathy - Autonomic disturbance - Cognitive impairment - Mood disturbance Pathology: intranuclear neuronal and astrocytic inclusions MRI findings: white matter lesions involving middle cerebellar penduncles
29
Features of Huntington's disease
- Autosomal dominant - Increased number of trinucleotide CAG repeats located on chromosome 4 (huntingtin gene) leads to degeneration in striatal neurons >37 repeats: symptomatic - Anticipation: greater number of repeats, earlier onset - Caudate atrophy - GABAergic neurons Clinical Features - Hyperkinetic movement disorder - Cognitive impairment - Depression - Psychosis - Oculomotor dysfunction Motor: - Dystonia (can be first sign) - Chorea, face and axial - Bradykinesia and rigidity (late stage or westphal variant) Cognitive - Can predate motor, can vary in severity - Executive function Most common cause of death is pneumonia and then suicide. TREATMENT - Chorea: tetrabenazine, AP (risperidone, olanzapine) - Parkinsonian feature: Levodopa - Antidepressants - Antipsychotics, mood stabilisers
30
Characteristics of serotonin syndrome
Overuse of serotonin drugs - SSRI: fluoxetine, citalopram, sertraline - SNRI: duloxetine, venlafaxine - Monoamine oxidase inhibitors: Phenelzine, Selegiline - Tricyclic antidepressants amitryptilline - Opioids: methadone, tramadol, oxycodone - Antiemetics: ondansetron, maxalon - MDMA, cocaine - St johns warts ``` HARM - Hypertherma- Autonomic instability - Rise in blood pressure - Myoclonus ``` Clinical Features Triad of mental status changes, neuromuscular hyperactivity, autonomic hyperactivity - Mental changes: agitation, hypervigilance, pressure speech delirium - Neuromuscular Hyperactivity: myoclonus, tremor, hyperreflexia, rigidity and clonus prominently in LL - Autonomic Hyperactivity: hypertension, tachycardia, diaphoresis, shivering, temperature > 40 ``` Tx Discontinuation of serotonergic drugs Supportive Care: Cooling measures: ice packs, cold compress Antihypertensives, fluid replacement Benzodiazepines for sedation Cyprohepatidine Serotonin antagonist Used for serotonin syndrome that do not respond to supportive care ```
31
Characteristics of Neuroleptic Malignant Syndrome
- Neuroleptic malignant syndrome (NMS) is a severe disorder caused by an adverse reaction to medications with dopamine receptor-antagonist properties or the rapid withdrawal of dopaminergic medications. - More common in 1st generation antipsychotics - Rapid escalation, multiple drugs, long acting forms Medications: - Typical antipsychotics: haloperidol, droperidol - Atypical: clozapine, olanzapine, risperidone, aripirazole, quetiapine - Other dopamine antagonist: metoclopramide, prochlorperazine, promethazine Clinical Features - Muscle rigidity (lead pipe rigidity, tremor - Autonomic dysfunction: hyperthermia, tachycardia - Altered conscious state Elevated CK (rhabdo) Leukocytosis Elevated transaminases FALTER: fever, autonomic instability, leukocytosis, tremor, elevated enymes (CK, transaminases), rigor Treatment: - Discontinouation of drug - Supportive - Dantrolene: muscle relaxant - Alternative: bromocriptine, benzos
32
Where is the area affected for the following conditions - Wernicke and Korsakoff syndrome - Hemiballism - Huntington chorea - Parkinsons disease - Kluver bucy syndrome - hypersexuality, hyperorality, hyperphagia, visual agnosia
Wernicke and Korsakoff syndrome: medial thalamus and mammillary bodies of the hypothalamus Hemiballismus - Unilateral violent flinging movements of limbs - Lesions of the contralateral SUBTHALAMIC NUCLEUS of the basal ganglia The ballisic movements primarily affect the proximal limb musculature whilst the distal muscles may display more choreiform-like movements Symptoms may decrease whilst the patient is asleep. Antidopaminergic agents (e.g. Haloperidol) are the mainstay of treatment - Huntington chorea: stratium (caudate nucleus) of the basal ganglia Chorea is caused by damage to the basal ganglia, in particular the Caudate nucleus - Parkinsons disease: substantia nigra (pars compacta) of the basal ganglia - Kluver bucy syndrome - hypersexuality, hyperorality, hyperphagia, visual agnosia: amygdala Hemiballismus – sudden flailing movements of contralateral limbs – lesion STN Chorea – dancelike – jerky, purposeless movements of limbs, face & tongue, eg. Huntington’s chorea (genetic – autosomal dominant) - results from degeneration of D2 GABA cells in striatum (which are part of the indirect pathway). Athetosis – slow writhing movements trunk and proximal limbs with varying degrees of spasticity, eg. cerebral palsy. Commonly combined with chorea – known as choreoathetosis.
33
Causes of drug induced PD
Dopamine antagonist Typical Ap: haloperidol, chlorpromazine Atypical: risperidone, olanzapine, aripiprazoel Antiemetics: metoclopramide Drug-induced parkinsonism may be distinguished from idiopathic Parkinson disease on the basis of the symmetry of symptoms and the absence of typical nonmotor features.
34
Features of essential tremor
Essential Tremor - Bilateral, largely symmetrical postural and kinetic tremor involving hands and forearms - Slow progression - Begins later in life 50-60s - May have concomitant head and jaw tremor (yes tremor) - Improves with alcohol - Familial in 50%, autosomal dominant - Involves cerebellar-thalamic circuit and dentate nucleus-red nucleus-inferior oliv circuit Tx: - propranolol and primidone - Topiramide - Clonazepam - DBS: ventral intermediate nucleus of the thalamus - Ultrasound thalamotomy
35
What should a patient be screened for if they have progressive dystonia, tremor, parkinsonism and elevated lfts
Wilson disease
36
Treatment for dystonia
Dystonia involves sustained stereotyped and directional twisting and posturing movements of various body parts. Medications include anticholinergics, benzodiazepines, baclofen - Botox injection - Trihexyphenidyl (Artane) - tremor dystonia
37
What is chorea and what is the cause?
Chorea consists of random, nonrepetitive, flowing dance like movements. Can be caused by antipsychotics, estrogen containing drugs, endocrine derangement (thyrotoxicosis, acute hyperglyacemia, pregnancy, streptococcal infection, autoimmune (sle, aps) Chorea describes involuntary, rapid, jerky movements which often move from one part of the body to another. Slower, sinuous movement of the limbs is termed athetosis. Chorea is caused by damage to the basal ganglia, especially the caudate nucleus. Causes of chorea - Huntington's disease, Wilson's disease, ataxic telangiectasia - SLE, anti-phospholipid syndrome - rheumatic fever: Sydenham's chorea - drugs: oral contraceptive pill, L-dopa, antipsychotics - neuroacanthocytosis - pregnancy: chorea gravidarum - thyrotoxicosis - polycythaemia rubra vera - carbon monoxide poisoning - cerebrovascular disease
38
Holmes tremor
- Unilateral, rest, postural, movement and worse on intention - Lesion in the midbrain tegmentum outside the red nucleus especially in the superior cerebellar peduncle or posterior part of thalamus, interrupting cerebellar outflow pathways - Horrendous tremor, super severe cerebellar tremor - Wilsons disease, stroke, MS
39
Dystonia
- Sustained or intermittent muscle contractions causing abnormal movements, often repetitive, patterned, twisting or tremulous - Lead to no-no tremor - Can worsen when you do an action that is opposite the dystonia - Can have task dependent dystonia Cervical dystonia Doapminergic + cholinergic involement TX - Levodopa trial - dopa responsive dystonia - Clonazepam, trihexyphenidyl (generalised) - Botulinum toxin (isolated) - DBS
40
What is leber disease
• Leber: mitochondrial condition leading to optic neuropathy ○ Inherited from maternal line ○ Occurs in high oxygen dependent areas - optic, ear, liver, small fibre neuropathy ○ PAINLESS progressive bilateral sequential vision loss, bilateral optic disc swelling ○ Can be very acute Primarily affects men
41
Features of Friedreich's Ataxia
Friedreich's ataxia is the most common of the early-onset hereditary ataxias. It is an autosomal recessive, trinucleotide repeat disorder characterised by a GAA repeat in the X25 gene on chromosome 9 (frataxin). Friedreich's ataxia is unusual amongst trinucleotide repeat disorders in not demonstrating the phenomenon of anticipation. The typical age of onset is 10-15 years old. Gait ataxia and kyphoscoliosis are the most common presenting features. ``` Neurological features absent ankle jerks/extensor plantars cerebellar ataxia optic atrophy spinocerebellar tract degeneration ``` Other features hypertrophic obstructive cardiomyopathy (90%, most common cause of death) diabetes mellitus (10-20%) high-arched palate Friedreich's ataxia is a genetic progressive neurodegenerative disorder. It causes degeneration of the corticospinal tracts, dorsal columns and spinocerebellar tracts, as well as hypertrophic cardiomyopathy and diabetes. Symptoms include ataxia, slurred speech, spasticity, dysphagia, limb sensory loss and vision and hearing loss. Symptoms are usually apparent by adolescence.
42
Treatment of PD with motor symptoms
For first-line treatment: - if the motor symptoms are affecting the patient's quality of life: levodopa - if the motor symptoms are not affecting the patient's quality of life: dopamine agonist (non-ergot derived - pramipexole, ropinirole, rotigotine), levodopa or monoamine oxidase B (MAO‑B) inhibitor Monoamine oxidase B inhibitos EG:: Rasagiline, Selegiline New Medication: - Safinamide - MAO B inhibitor + glutamate release inhibitor - leads to increased ON time without troublesome dyskinesias
43
Movement disorders in order of least speed to fastest (DACB)
Dystonia - fixated position Athetosis - Snake-like writhing (slow) Choreiform - Like a dance choreographer Ballistic/Ballismus/Hemiballismus - Fast flinging movements, can injure themselves or others 'like a ballistic missile' (memorisation method)
44
Causes of parkinsonism
Causes of Parkinsonism • Parkinson's disease • drug-induced e.g. antipsychotics, metoclopramide* • progressive supranuclear palsy • multiple system atrophy • Wilson's disease • post-encephalitis • dementia pugilistica (secondary to chronic head trauma e.g. boxing) • toxins: carbon monoxide, MPTP *Domperidone does not cross the blood-brain barrier and therefore does not cause extra-pyramidal side-effects
45
Intention tremor localisation
Intention tremor is the result of dysfunction of the CEREBELLUM, particularly on the same side as the tremor in the lateral zone, which controls visually guided movements. Depending on the location of cerebellar damage, these tremors can be either unilateral or bilateral.
46
Intention vs Essential Tremor
In essential tremor, an area of the brain called the thalamus sends faulty electrical signals causing the hands, arms, head or voice to shake uncontrollably. While both intention and essential tremor are characterized by muscle oscillations, intention tremors are slower, zigzag-like movements which are evident when intentionally moving towards a target, whereas an essential tremor is a neurological disorder that can lead to tremors without accompanying intentional movements.
47
Features of intention tremor
- Intention tremors are a type of kinetic tremor, which become apparent during voluntary and intentional movement. - They typically affect the upper limbs, but can also involve other body parts. Causes: - MS (most common) - Cerebellar lesion - Hereditary disorders, metabolic conditions, psychological conditions, or exposure to toxic substances.
48
New medications in parkinson's disease
Safinamide - MOA B inhibitor + glutamate release inhibitor - Increased "on" time without troublesome dyskinesias Potential Neuromodulatory Treatments - Glucagon like peptide 1 receptor agonist: Exenatide - Used in T2DM - Neuroprotective effects in animal models - Improvement in motor symptoms in "off" state Future Treatment - Stem cell therapy Foetal ventral mesencephalon dopamine producing neuroblasts
49
What is an essential tremor plus
Characteristic tremor PLUS: - Mild neurological signs, eg: impaired tandem gait, dystonic posturing, cognitive impairment - Action PLUS resting tremor
50
Features of Tourette Syndrome
Motor and Vocal tics - Blinking, grimacing, shrugging, head jerking - Grunting, barking, throat clearing, sniffing - Complex: echo/coprapraxia, echo/copralalia (vulgar writings/involuntary profane drawings) - Abilit to suppress, urge to perform Associated with ADHD, OCD, learning disorder, mood disorder Tx: - Habit reversal training - Tetrabenazine, Risperidone - ADHD - clonidine - OCD -SSRI
51
Tardive Dyskinesia and Drug Induced Parkinsonism
Tardive Dyskinesia: delayed onset of orofacial dyskinesia in the context of antipsychotic use Drug induced parkinsonism: symmetrical extrapyramidal signs Tx: - Reduce antipsychotic - Change to atypical antiosychotic - Tetrabenazine, Benztropine
52
Wilsons Disease
- Dysarthria - Dystonia - Tremor - Rigidity - Chorea - Ataxia - Behaviour, cognitive and mood disturbance - Liver disease Mean Age of Onset - Hepatic: 9-13yo - Neurological 15-21yo - Autosomal RECESSIVE, ATP7B gene - Disorder of copper metabolism Diagnosis - Low serum ceruloplasmin - High urinary copper - Kayser Fleischer Rings - High copper on liver biopsy Treatment - Chelating Agents: penicillamine or trientene + zinc - Levodopa - Antipsychotics + antidepressants - Liver transplant